Skip to main content
. 2023 Jul 11;28(11):e981–e994. doi: 10.1093/oncolo/oyad138

Figure 2.

Figure 2.

(A) Worldwide prevalence of KRAS G12C mutations in the entire cohort of included populations with colorectal cancer. (B) Worldwide prevalence of KRAS G12C mutations within the KRASm population in patients with colorectal cancer. *JAPAC, Japan & Asia-Pacific regions; **Intercontinental region: South America, Middle East. Abbreviation: KRASm, Kirsten rat sarcoma virus gene mutations.